27 results on '"Waluś-Miarka, Małgorzata"'
Search Results
2. Aortic valve and arterial calcification in patients with familial hypercholesterolemia.
3. Carotid artery plaques – Are risk factors the same in men and women with familial hypercholesterolemia?
4. Targeted sequencing of a gene panel in patients with familial hypercholesterolemia from Southern Poland.
5. A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
6. Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency
7. Effectiveness and safety of PCSK9 inhibitor therapy in patients with familial hypercholesterolemia within a therapeutic program in Poland: Preliminary multicenter data.
8. Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes.
9. Correlates of pentraxin 3 serum concentration in men and women with type 2 diabetes.
10. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland
11. Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease.
12. Pentraxin 3 concentration is positively associated with apo C3 and abdominal obesity in men with type 2 diabetes
13. Pentraxin 3 concentration in patients with type 2 diabetes mellitus and NAFLD
14. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia.
15. Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries.
16. Intima-media thickness correlates with features of metabolic syndrome in young people with a clinical diagnosis of familial hypercholesterolaemia.
17. Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients
18. Authors' reply.
19. Is now the time for probiotics in diabetes management?
20. Aortic valve and arterial calcification in patients with familial hypercholesterolemia.
21. Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. Authors' reply.
22. Is now the time for probiotics in diabetes management?
23. [Determinants of nonalcoholic fatty liver disease in men and women with type 2 diabetes].
24. Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes.
25. Intima-media thickness correlates with features of metabolic syndrome in young people with a clinical diagnosis of familial hypercholesterolaemia.
26. [Autosomal dominant hypercholesterolemia - underrecognised diagnostic and clinical problem].
27. [Arterial wave velocity and coronary risk factors in patients with type-2 diabetes].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.